Investor List:

Top Drug Delivery Series B Investors (39)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Cybersecurity (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Washington, D.C. (Other Lists)
Photo of Greg Kubin, General Partner at PsyMed Ventures
Greg Kubin
PsyMed Ventures·General Partner
Sweet spot: $250K
Range: $100K - $2.0M
Photo of Kelly Qiao, Principal at B Capital Group
Kelly Qiao
B Capital Group·Principal
Sweet spot: $25.0M
Range: $25.0M - $60.0M
Investors in China
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Hardware (Seed), Investors in Therapeutics (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Hardware (Series A), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Bhavik Nagda, Investor at Bessemer Venture Partners
Bhavik Nagda
Sweet spot: $1M
Range: $50K - $200.0M
Investors in Massachusetts
Investors in Drug Delivery (Seed), Investors in GovTech (Seed), Investors in DeepTech (Seed), Investors in Enterprise Infrastructure (Seed), Investors in Robotics (Seed), Investors in IoT (Seed), Investors in Cloud Infrastructure (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Drug Delivery (Series A), Investors in GovTech (Series A), Investors in DeepTech (Series A), Investors in Enterprise Infrastructure (Series A), Investors in Robotics (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Cloud Infrastructure (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Drug Delivery (Series B), Investors in GovTech (Series B), Investors in DeepTech (Series B), Investors in Robotics (Series B), Investors in Enterprise Infrastructure (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Cloud Infrastructure (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Investors who were founders (Other Lists)
Photo of Lionel Carnot, Partner at Earlybird Venture Capital
Lionel Carnot
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Photo of Michael Jelinske, Investor at LeapFrog Investments
Michael Jelinske
Sweet spot: $40
Range: $20 - $60